Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis [0.03%]
一例致命性免疫检查点抑制剂相关肺炎的放射学和尸检结果
Meghan Shea,Deepa Rangachari,Robert W Hallowell et al.
Meghan Shea et al.
Oncologists are increasingly managing drug-induced pneumonitis in lung cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors. To date only few studies on the topic have described both radiologic and pathologic findings in the...
Benefit of crizotinib in a lung cancer patient with discordant ALK testing results [0.03%]
ALK检测结果不一致的肺癌患者克唑替尼治疗有效
Steven Grocholski,Shantanu Banerji,Gefei Qing et al.
Steven Grocholski et al.
Crizotinib is a first line treatment for patients with non-small cell lung cancer (NSCLC) harboring translocations in anaplastic lymphoma kinase (ALK). The current gold standard for determining ALK status is fluorescence in-situ hybridisati...
A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma [0.03%]
评价霍奇金淋巴瘤既往胸部放疗的乳腺癌患者化疗耐受性的回顾性研究
Allison P Watson,Bruce Peterson,Chung Lee et al.
Allison P Watson et al.
Microabstract: Women treated with chest radiation for Hodgkin lymphoma (HL) have significantly higher risk of developing breast cancer, and little is known about how these patients tolerate chemotherapy for breast cancer....
Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice [0.03%]
关于广泛期小细胞肺癌放射治疗管理的调查研究通讯
Kate Haslett,Dirk De Ruysscher,Rafal Dziadziuszko et al.
Kate Haslett et al.
Objectives: The results of the randomized phase 3 CREST trial evaluating the use of thoracic radiotherapy for extensive-stage small-cell lung cancer (ES-SCLC) were published in the Lancet in 2015. The primary endpoint (10...
Multicenter Study
Cancer treatment and research communications. 2018:17:18-22. DOI:10.1016/j.ctarc.2018.08.004 2018
Next generation T-cell therapy for genitourinary malignancies, part A: Introduction and current state of the art [0.03%]
下一代T细胞治疗泌尿生殖系肿瘤（上）：介绍和目前的最新进展
Morgan Pantuck,Nicolaos Palaskas,Alexandra Drakaki
Morgan Pantuck
Clinical characteristics and survival of patients with multiple metachronous esophageal tumor [0.03%]
异时性多发食管肿瘤患者的临床特征及生存分析
Fahad Mukhtar,Omonigho M Bubu,Luu Hung N
Fahad Mukhtar
Background: The aim of this study is to determine the clinical characteristics and predictors of survival for patients with multiple metachronous esophageal tumors (MMET) and to compare the survival with patients that hav...
Comparative Study
Cancer treatment and research communications. 2018:17:13-17. DOI:10.1016/j.ctarc.2018.08.003 2018
Next generation T-cell therapy for genitourinary malignancies, part B: Overcoming obstacles and future strategies for success [0.03%]
下一代T细胞治疗泌尿生殖系统肿瘤（B）：克服障碍和未来成功战略
Morgan Pantuck,Nicolaos Palaskas,Alexandra Drakaki
Morgan Pantuck
Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status [0.03%]
对于BRCA阴性或BRCA状态未知的铂耐药或部分铂敏感复发的卵巢上皮癌患者的veliparib和拓扑替康疗法
Mette Hjortkjær,Hanne Kanstrup,Anders Jakobsen et al.
Mette Hjortkjær et al.
Comparative assessment of late toxicity in patients of carcinoma cervix treated by radiotherapy versus chemo-radiotherapy - Minimum 5 years follow up [0.03%]
宫颈癌放射治疗与放化疗晚期反应的比较分析-至少五年以上的随访数据回顾
Shagun Misra,Punita Lal,Saibish Kumar Ep et al.
Shagun Misra et al.
Background: A randomised trial was carried out comparing chemo-radiation (CTRT) vs. radiotherapy (RT) in patients of carcinoma cervix and showed similar rates of pelvic disease control, disease free survival and overall s...
Comparison of endometriotic cysts and ovarian cancer in association with endometriotic cysts [0.03%]
卵巢子宫内膜异位囊肿与伴有子宫内膜异位囊肿的卵巢癌的比较
Yorito Yamamoto,Akiko Wakikawa,Akiko Ueno et al.
Yorito Yamamoto et al.
Objective: The aim of this study was to clarify the clinical, laboratory, and imaging findings of ovarian cancer in association with endometriotic cysts by detailed comparison of the findings of benign and malignant tumor...
Comparative Study
Cancer treatment and research communications. 2018:14:26-29. DOI:10.1016/j.ctarc.2017.11.002 2018